249
Participants
Start Date
July 31, 2015
Primary Completion Date
June 30, 2017
Study Completion Date
June 30, 2017
Asimadoline
kappa-opioid receptor agonist
Placebo
placebo-matched control
Corning Center for Clinical Research, Corning
University of Pennsylvania, Department of Dermatology, Philadelphia
Temple Itch Center, Philadelphia
Wake Forest Baptist Health, Winston-Salem
UNC Dermatology and Skin Cancer Center, Chapel Hill
Medical Research South, Charleston
National Allergy and Asthma Research, LLC, North Charleston
Radiant Research, Inc., Anderson
Park Avenue Dermatology, Orange Park
Tory Sullivan, MD PA, North Miami Beach
Olympian Clinical Research, Tampa
Clinical Research Center of Alabama, Birmingham
Forefront Dermatology, Carmel
Sneeze, Wheeze and Itch Associates, LLC, Normal
MediSearch Clinical Trials, Saint Joseph
Dermatology Treatment and Research Center, PA, Dallas
Sylvana Research Associates, San Antonio
Northwest Clinical Trials, Boise
Children's Hospital Los Angeles, Los Angeles
Axis Clinical Research, Los Angeles
Oregon Health and Science University, Portland
The Dermatology Group, Verona
Lead Sponsor
Tioga Pharmaceuticals
INDUSTRY